Clinical trial

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

NCT00899028

Drugs and interventions used in this trial

10 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention comparative genomic hybridization Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention fluorescence in situ hybridization Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention gene expression analysis Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention microarray analysis Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention protein expression analysis Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention immunohistochemistry staining method Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention laboratory biomarker analysis Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention matrix-assisted laser desorption/ionization time of flight mass spectrometry Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention medical chart review Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention diagnostic bronchoscopy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2001-05-01

PhaseN/A

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

comparative genomic hybridizationGENETIC

fluorescence in situ hybridizationGENETIC

gene expression analysisGENETIC

microarray analysisGENETIC

protein expression analysisGENETIC

immunohistochemistry staining methodOTHER

laboratory biomarker analysisOTHER

matrix-assisted laser desorption/ionization time of flight mass spectrometryOTHER

medical chart reviewOTHER

diagnostic bronchoscopyPROCEDURE

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

NashvilleTennessee, United States4

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00899028 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.